(Press-News.org) WHAT:
The monthly dapivirine vaginal ring and daily oral pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine were each found to be safe for HIV prevention among cisgender women who started using one of them in their second trimester of pregnancy, according to findings presented today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver. Pregnant people are estimated to be three times more likely to acquire HIV through sexual intercourse than similarly aged people who are not pregnant.
The large clinical study was conducted in South Africa, Uganda and Zimbabwe by the Microbicide Trials Network, an international research network funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health.
The dapivirine ring is made of flexible silicone, continuously releases the antiretroviral drug dapivirine into the vagina, and is replaced monthly by the user. It is approved in several African countries and recommended by the World Health Organization for HIV prevention. Data have been limited on dapivirine ring use in pregnancy. Some participants in previous studies became pregnant while using the ring and discontinued use promptly with no concerning findings, however it had not been specifically studied in this priority population. The safety of oral PrEP with tenofovir disoproxil fumarate and emtricitabine has been well established among pregnant cisgender women with HIV taking them as part of a treatment regimen. Several country regulatory agencies have requested data on oral PrEP use during pregnancy for prevention to complement that evidence.
Participants were aged 18-40 and randomized to receive the ring or oral PrEP until delivery or 41 weeks and six days, whichever came first. Of 248 pregnancies, 1% experienced stillbirth or miscarriage, 95% of deliveries were at term and 4% were preterm. Four percent of live births had congenital anomalies, none of which were related to study products. These trends and other pregnancy complications occurred at a similar frequency to a reference dataset of more than 10,000 deliveries at the same hospitals and no study participants acquired HIV.
According to the authors, the findings, along with those from earlier cohorts in the large clinical study, as well as observed pregnancy outcomes in other studies of these products, demonstrate the ring and oral PrEP to both be safe for HIV prevention throughout pregnancy.
For more information about this trial, please visit ClinicalTrials.gov study identifier NCT03965923.
PRESENTATION:
Mhlanga et al. Safety of Dapivirine Vaginal Ring and Oral PrEP for HIV Prevention in the Second Trimester. Conference on Retroviruses and Opportunistic Infections in Denver, Colorado. Tuesday, March 5, 2024.
WHO:
Carl W. Dieffenbach, Ph.D., Director of the Division of AIDS, is available to discuss this research.
CONTACT:
To schedule interviews, please contact NIAID News & Science Writing Branch, (301) 402-1663, niaidnews@niaid.nih.gov.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH...Turning Discovery Into Health®
END
Michelson Medical Research Foundation (MMRF) and Human Immunome Project (HIP) have awarded Dr. Siyuan Ding (Washington University in St. Louis), Dr. Claire Otero (Weill Cornell Medicine), and Dr. Dennis Schaefer-Babajew (Rockefeller University) the Michelson Prizes: Next Generation Grants, the organizations announced today.
The $150,000 research grants are awarded annually to support early-career scientists advancing human immunology, vaccine discovery, and immunotherapy research for major global ...
Since more than a decade it has been possible for physicists to accurately measure the location of individual atoms to a precision of smaller than one thousandth of a millimeter using a special type of microscope. However, this method has so far only provided the x and y coordinates. Information on the vertical position of the atom – i.e., the distance between the atom and the microscope objective – is lacking. A new method has now been developed that can determine all three spatial coordinates of an atom with one single image. This method – developed by the University of Bonn and University of Bristol ...
CLEVELAND – New Cleveland Clinic-led research points to sildenafil (Viagra) as a potential treatment for Alzheimer’s disease. The study provides evidence from computational models, insurance claims data and observations from brain cells in Alzheimer’s patients.
Sildenafil is the main component of drugs used to treat erectile dysfunction (Viagra) and pulmonary arterial hypertension (Revatio).
“Our findings provide further weight to re-purposing this existing FDA-approved drug as a novel treatment for Alzheimer’s, which is in great need of new therapies,” ...
Antarctic researchers hitched a lift on a cruise ship, and recommend this eco-friendly, collaborative approach to remote ocean science.
####
Article URL: https://journals.plos.org/climate/article?id=10.1371/journal.pclm.0000348
Article Title: New methods of undertaking marine science in Antarctica using tourism vessels
Contact: Matthew Mulrennan; matt@kolossal.org
Author Countries: Canada, United States
Funding: The authors received no specific funding for this work. END ...
March 5, 2024, Mountain View, CA – The moon lander Odysseus, known as Odie, touched down on the Moon's surface on February 22, becoming the first time the U.S. has landed on the Moon in more than 50 years and the first commercial moon lander to successfully land on the Moon. Along with its science payload, the spacecraft also brought along a fusion of art and space exploration, SETI Institute's Artist in Residence (SETI AIR), Felipe Pérez Santiago's Earthling Project, a collection of global musical compositions representing Earth's cultural ...
Beckman Institute for Advanced Science and Technology researchers Jonathan Sweedler, a professor of chemistry, and Fan Lam, a professor of bioengineering, outlined how spatial omics technologies can reveal the molecular intricacy of the brain at different scales.
Their research appeared this month in Nature Methods.
The researchers and their colleagues used a biochemical imaging framework integrated with deep learning to create 3D molecular maps with cell specificity to better understand how the brain functions in health and disease. Their research is supported by a $3 million grant from ...
WHAT:
A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver. This is the first clinical trial of semaglutide for MASLD in people with HIV. The research was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and conducted in the United States and Brazil by ACTG, a global clinical trials network focused on HIV and other infectious diseases. ...
The Lancet: Experts warn about the overmedicalisation of menopause and call for a new approach to how society views menopause and supports women as they age
Menopause is a life stage for half the world’s population and is generally depicted in a negative way. However, women’s experiences of menopause are unique and vary hugely.
The Lancet 2024 Series on menopause argues that an over-simplified narrative of menopause as a health problem to be solved by replacing hormones is not based on evidence and deflects attention from the need for substantial societal shifts in how menopause, and midlife/older women in general, are viewed and treated around the world.
The ...
A new review paper from authors at Brigham and Women’s Hospital and collaborators concludes that menopause does not uniformly elevate the risk of depression and other mental health conditions.
Menopause has long been thought to cause psychological distress, but a new review suggests that this is not always the case. The review, written by experts from Brigham Women’s Hospital, a founding member of the Mass General Brigham healthcare system, and international collaborators, is the third in a series of menopause-themed papers published in The ...
1. A research team consisting of NIMS and the Tokyo Institute of Technology has identified materials capable of catalyzing the conversion of ortho-hydrogen to para-hydrogen. These catalysts should be essential to the spread of mass-transportation/storage of liquid hydrogen.
2. Hydrogen is becoming widely accepted as an alternative energy source to fossil fuels. Its liquefaction (at temperatures below -253°C under pressures higher than one atmosphere) can dramatically reduce its volume, making it suitable for transportation and storage. Hydrogen molecules (H2)—each composed of two hydrogen atoms—exist in two isomeric forms: ortho- and para-H2. Under normal conditions, ...
